Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1)
Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1)
Active, not recruiting · NCT07109414 · Registry updated 2026-03-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1) | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder | Active, not recruiting | Phase 2 / Phase 3 | 2026-03-09 | NCT07109414 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gynecologic Oncology Group | 9 |
| Novita Pharmaceuticals, Inc. | 1 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| HonorHealth Cancer Care | Phoenix | United States | 1 |
| Optimum Clinical Research Group, LLC | Albuquerque | United States | 2 |
| Trials365 | Shreveport | United States | 1 |
| University of Pennsylvania Health System, Perelman Center for Advanced Medicine | Philadelphia | United States | 1 |
| University Of Wisconsin Carbone Cancer Center | Madison | United States | 1 |
| Utah Cancer Specialists | Salt Lake City | United States | 29 |